Sodium t-butoxide → N-[3-[[4-(3-cyano-4-pyrrolidin-1-ylphenyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide

HRID 1852411ノート

反応式

HRID 1852411 の反応式
Cl[C:2]1[N:7]=[C:6]([C:8]2[CH:9]=[CH:10][C:11]([N:16]3[CH2:20][CH2:19][CH2:18][CH2:17]3)=[C:12]([CH:15]=2)[C:13]#[N:14])[CH:5]=[CH:4][N:3]=1.[NH2:21][C:22]1[CH:23]=[C:24]([NH:28][C:29]([N:31]2[CH2:35][CH2:34][CH2:33][CH2:32]2)=[O:30])[CH:25]=[CH:26][CH:27]=1.CC([O-])(C)C.[Na+]>O1CCOCC1.O.CCOC(C)=O.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[C:13]([C:12]1[CH:15]=[C:8]([C:6]2[CH:5]=[CH:4][N:3]=[C:2]([NH:21][C:22]3[CH:23]=[C:24]([NH:28][C:29]([N:31]4[CH2:35][CH2:34][CH2:33][CH2:32]4)=[O:30])[CH:25]=[CH:26][CH:27]=3)[N:7]=2)[CH:9]=[CH:10][C:11]=1[N:16]1[CH2:20][CH2:19][CH2:18][CH2:17]1)#[N:14]

参加物

8

反応物 3

HCID 23676156Sodium t-butoxideHCID 29798917n-(3-Aminophenyl)pyrrolidine-1-carboxamideHCID 866983255-(2-Chloro-pyrimidin-4-yl)-2-pyrrolidin-1-yl-benzonitrile

生成物 1

HCID 56646418N-[3-[[4-(3-cyano-4-pyrrolidin-1-ylphenyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide

試薬・触媒・溶媒 4

HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 962Water溶媒HCID 8857Ethyl Acetate溶媒HCID 312751,4-Dioxane溶媒

反応条件

温度
100 °C

実験手順

5-(2-Chloro-pyrimidin-4-yl)-2-pyrrolidin-1-yl-benzonitrile (40 mg, 0.141 mmol), pyrrolidine-1-carboxylic acid (3-amino-phenyl)-amide (29 mg, 0.141 mmol), Pd2(dba)3 (6.4 mg, 0.007 mmol, 5 mol %), 2-dicyclohexylphosphino-2′-(N,N-dimethylaminobiphenyl) (55.5 mg, 0.141 mmol) and NaOtBu (20.3 mg, 0.211 mmol) were dissolved in 1,4-dioxane (1 mL) and the mixture heated at 100° C. in the microwave (300 W, stirring) for 10 minutes. The mixture was diluted with H2O (10 mL) and EtOAc (30 mL) and the layers separated. The aqueous phase was extracted with EtOAc (20 mL) and the combined organics dried (MgSO4), filtered and the solvent evaporated in vacuo. The mixture was dissolved in DMSO (1.5 mL) and the crude product purified by reversed phase preparative LC-MS. Fractions containing desired product were combined and the solvent evaporated in vacuo. The title compound was afforded as a yellow solid (13.1 mg, 21%); LC-MS, Rt=6.50 min (ANALpH2_MeOH_QC), m/z 453 (MH+).

後処理

  1. customthe layers separated
  2. extractionThe aqueous phase was extracted with EtOAc (20 mL)
  3. dry with materialthe combined organics dried (MgSO4)
  4. filtrationfiltered
  5. customthe solvent evaporated in vacuo
  6. dissolutionThe mixture was dissolved in DMSO (1.5 mL)
  7. customthe crude product purified by reversed phase preparative LC-MS
  8. additionFractions containing desired product
  9. customthe solvent evaporated in vacuo

出典と根拠

ORDレコード
ord-41334ddd463b42ab9ef62cbb8700000e
出典データセット
uspto-grants-2015_02
特許番号
US08962609B2

反応ノート

読み込み中…